Primer: ProKidney (PROK US) - Aug 2026
ProKidney is a late-stage biotechnology company developing a potentially disruptive, first-in-class autologous cell therapy, rilparencel...
89 Views
The Nightcap from SPAC Track
Social Capital Suvretta Holdings Corp. III (DNAC: no warrants, common +0.01%) &Â ProKidney. Vishal Garg, founder and CEO of digital mortgage lender...
385 Views
These Dealmakers will Make or Break SPACs in 2022
While a majority of SPAC dealmakers have faced issues such as raising adequate financing for deals or acquiring high-quality merger targets, Serial...
655 Views
The Nightcap from SPAC Track
Exactly one year to the day after Chamath Palihapitiya’s last SPAC deal announcement, we have news that one of his four biotech SPACs is in talks...
369 Views